Quantic Nanotech S.L. Receives Global 100 Award for Most Innovative Digital Rheumatism & Osteoarthritis Health Product 2025

Quantic Nanotech S.L., a trailblazing division of DEMAC S.A., has been honored with the prestigious Global 100 Award for “Most Innovative Digital Rheumatism & Osteoarthritis Health Product” in 2025. This accolade recognizes the company’s groundbreaking contributions to digital health solutions, particularly in the realm of rheumatism and osteoarthritis care.

Pioneering Digital Health Solutions

At the heart of Quantic Nanotech’s innovation is the Quantic Glove System, an advanced electronic glove designed to alleviate joint pain and stiffness associated with osteoarthritis in the hands. This state-of-the-art device integrates multiple therapeutic modalities, including dry heat therapy, mechanical micropulses, and passive stretching, all controlled through an intuitive electronic interface. The system is complemented by disposable gloves infused with high-quality ingredients such as argan oil, calendula, purslane, and horse chestnut, providing anti-inflammatory benefits and enhancing overall hand health.

The Quantic Glove System is designed for convenient home use, allowing patients to manage their therapy sessions with ease. Each session lasts approximately 20 minutes, and the device’s portability ensures that users can incorporate treatment seamlessly into their daily routines. The system is powered by rechargeable lithium-ion batteries, offering up to two weeks of use on a single charge, and features a magnetic connector for effortless recharging.

Clinical Validation and Recognition

The efficacy of the Quantic Glove System has been substantiated through rigorous clinical trials. In December 2022, results from a multicenter open-label clinical trial were presented at the Congress of the Rheumatology Society of the Community of Madrid (SORCOM). The study demonstrated significant improvements in pain reduction and functional capacity among patients with hand osteoarthritis. 

This recognition by the Global 100 Awards adds to Quantic Nanotech’s history of accolades. The company has previously been honored at international forums such as InPEX Pittsburgh, ITEX Indonesia, and the Geneva International Exhibition of Inventions, highlighting its commitment to innovation and excellence in health technology. 

A Legacy of Innovation

Founded in 1992 by a team of visionary engineers led by Mr. Jose Luis de la Torre, DEMAC S.A. has consistently prioritized research and development across various sectors. Quantic Nanotech, as a specialized division, embodies this ethos by focusing on health-related technologies. The company’s extensive patent portfolio reflects its dedication to creating solutions that address real-world health challenges, particularly in the management of rheumatic and osteoarthritic conditions. 

Looking Ahead

Building on this esteemed recognition, Quantic Nanotech is poised to expand its product offerings and explore new therapeutic avenues. Collaborations with medical institutions and ongoing research initiatives aim to enhance the efficacy of existing treatments and develop innovative solutions that improve the quality of life for individuals affected by rheumatic and osteoarthritic conditions.

For more information about Quantic Nanotech’s products and research initiatives, visit www.qnanotech.com.